Directory
>
Scott Ribich
Scott Ribich
Vice President, Head of Discovery Biology | Blueprint Medicines
Cambridge, Massachusetts, United States
Scott Ribich
Summary
Scott Ribich is an accomplished Vice President and Head of Discovery Biology at Blueprint Medicines, specializing in preclinical drug discovery research. With a strong background in biotechnology, molecular biology, and drug discovery, he has held various leadership roles in multiple organizations, including Accent Therapeutics and Epizyme. Scott's academic foundation includes a Ph.D. from Harvard University, where he focused on biochemistry. His research experience spans over two decades, showcasing his commitment to advancing the pharmaceutical industry. He is known for his strategic vision and ability to lead diverse teams toward innovative solutions. Outside of his professional pursuits, Scott is passionate about fostering collaboration within the scientific community to drive breakthroughs in medicine.
Scott Ribich
Work Experience
Vice President, Head of Discovery Biology at
Blueprint Medicines
April 2022 - Present
Senior Vice President of Biology at
Accent Therapeutics, Inc.
January 2022 - March 2022
Vice President of Biology at
Accent Therapeutics, Inc.
October 2017 - January 2022
Director, Biological Sciences at
Epizyme
March 2016 - September 2017
Associate Director, Biological Sciences at
Epizyme
March 2014 - March 2016
Principal Scientist, Biological Sciences at
Epizyme
September 2012 - March 2014
Senior Scientist, Biological Sciences at
Epizyme
May 2011 - September 2012
Senior Scientist, Department of Cell Biology at
Sirtris Pharmaceuticals
May 2010 - May 2011
Scientist, Department of Cell Biology at
Sirtris Pharmaceuticals
August 2008 - May 2010
Postdoctoral Research Fellow at
Brigham and Women's Hospital
August 2006 - August 2008
Postdoctoral Fellow at
Harvard University
December 2005 - July 2006
Graduate Student at
Harvard University
January 1999 - January 2005
Research Student at
Takeda Oncology
January 1996 - January 1997
Scott Ribich
Education
Harvard University, Ph.D.
January 1999 - January 2005
Massachusetts Institute of Technology, S.B.
January 1994 - January 1998
Belmont Hill School
January 1989 - January 1994
Frequently Asked Questions about Scott Ribich
What is Scott Ribich email address?
Scott Ribich's primary email address is *******@blueprintmedicines.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Scott Ribich work for?
Scott Ribich is a Vice President, Head of Discovery Biology at Blueprint Medicines, a company specializing in Commercial physical research.
Where Scott Ribich graduated from?
Scott Ribich holds a degree in Biochemistry from Harvard University.
How can I directly contact Scott Ribich?
To contact Scott Ribich directly, you can use the email address *******@blueprintmedicines.com. Complete contact information is available upon registration with Muraena.
Who is Scott Ribich?
Scott Ribich is an accomplished Vice President and Head of Discovery Biology at Blueprint Medicines, specializing in preclinical drug discovery research. With a strong background in biotechnology, molecular biology, and drug discovery, he has held various leadership roles in multiple organizations, including Accent Therapeutics and Epizyme. Scott's academic foundation includes a Ph.D. from Harvard University, where he focused on biochemistry. His research experience spans over two decades, showcasing his commitment to advancing the pharmaceutical industry. He is known for his strategic vision and ability to lead diverse teams toward innovative solutions. Outside of his professional pursuits, Scott is passionate about fostering collaboration within the scientific community to drive breakthroughs in medicine.
Scott`s contact details
*******@blueprintmedicines.com
Colleagues
Senior Vice President
Senior Vice President, Strategic Operations
Senior Vice President, Information Systems
Chief Commercial Officer
Director
SVP, Finance and Accounting
Vice President, Tax & Treasury
Chief Medical Officer
Vp, Drug Safety & Pharmacovigilance
Vice President and General Manager Region Italy, Iberia, France and Benelux at Blueprint Medicines